Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
Archives of Dermatological Research · 2023
DOI: 10.1007/s00403-023-02560-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2023. Verfasst von Giulia Gasparini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Secction of Dermatology, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. giulia.gasparini@unige.it. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Autoimmune Diseases, Extracellular Vesicles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Genova.
Abstract (Originalsprache)
Bullous pemphigoid (BP) is an autoimmune blistering disease that targets the haemidesmosomal proteins, mainly BP180. Extracellular vesicles (EVs) have been demonstrated to carry tissue-specific autoantigens in the setting of autoimmune diseases and transplant organ rejection; this phenomenon was demonstrated to have pathogenic implications in autoimmune diseases and to correlate with transplant rejection severity. The purpose of this study was to identify the presence of BP targeted autoantigens in blister fluid derived EVs. We isolated, by size exclusion chromatography, EVs derived from blisters of BP-patients and from suction blisters of healthy donors. EV characterization was performed by flow cytometry and nanoparticle tracking analysis. Western blot analysis was used to investigate the presence of autoantigens. A suspension enriched in EVs was efficiently obtained from blister fluid from patients and healthy donors. EV-enriched fractions were enriched in particles with a size distribution characterizing small-EVs (main peak was present at 94.5 nm). BP180 was found, by western blot analysis, in EVs derived from blister fluid of 3 out 6 BP patients and in none of EVs isolated from suction blister fluid of healthy donors. BP230 and Dsg1 were not detectable in EVs of any of the samples. No specific clinical characteristics seemed to correlate to the presence of BP180 in EVs. The discovery of BP180 in EVs derived from blister fluid might help understanding BP pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Secction of Dermatology, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. giulia.gasparini@unige.it.
- Dermatology Unit, Ospedale Policlinico San Martino IRCCS, Genoa, Italy. giulia.gasparini@unige.it.
- Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy. giulia.gasparini@unige.it.
- Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
- Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome, Italy.
- Dermaology Unit IDI-IRCCS, Rome, Italy.
Förderung
- Università degli Studi di Genova
Zitieren
APA
Gasparini, G., Tasso, R., Palamà, M. E. F., Ciferri, M. C., Gentili, C., Di Zenzo, G., Provini, A., Salemme, A., Quarto, R., Parodi, A., & Cozzani, E. (2023). Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients. Archives of Dermatological Research. https://doi.org/10.1007/s00403-023-02560-2
Vancouver
Gasparini G, Tasso R, Palamà MEF, Ciferri MC, Gentili C, Di Zenzo G, et al. Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients. Archives of Dermatological Research. 2023. doi:10.1007/s00403-023-02560-2
BibTeX
@article{Gasparini2023,
author = {Gasparini, Giulia and Tasso, Roberta and Palamà, Maria Elisabetta Federica and Ciferri, Maria Chiara and Gentili, Chiara and Di Zenzo, Giovanni and Provini, Alessia and Salemme, Adele and Quarto, Rodolfo and Parodi, Aurora and Cozzani, Emanuele},
title = {Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients},
journal = {Archives of Dermatological Research},
year = {2023},
doi = {10.1007/s00403-023-02560-2}
}
EUVIMED